Stock Movers: Arm, Qualcomm, Expedia (Podcast)

Expedia raised its 2026 revenue and adjusted EBITDA-margin targets, expecting gross bookings to rise 10% as travel demand remains robust. Qualcomm forecast December-quarter sales of $10.4 billion to $11.2 billion; vehicle-electronics revenue grew 89% to $2 billion last quarter, offsetting a 26% decline in phone revenue to $5.14 billion, and shares rose about 4% in extended trading. Arm forecast fiscal third-quarter sales of about $1.54 billion, in line with analyst estimates, and said its new CPU could generate up to $2 billion in revenue during fiscal 2027 and 2028.

Analysis

The key distinction is earnings quality, not headline growth: Qualcomm’s diversification can reduce handset-cycle sensitivity, but vehicle design wins monetize over long ramps and do not yet prove durable replacement for a sharp phone slowdown. Verify whether automotive growth converts to sustained segment profitability and whether data-center demand is material rather than an early pipeline signal. For Arm, an in-line near-term outlook leaves the investment case increasingly dependent on management’s multi-year CPU revenue ambition; custom silicon adoption could expand Arm’s addressable market while also strengthening hyperscalers’ bargaining power over suppliers. That makes execution and monetization—not architecture adoption alone—the relevant test.

Expedia’s raised targets support resilience in travel, but bookings growth is not equivalent to margin growth. Strong premium demand may help mix, while higher airfares can pressure affordability and conversion in lower-income cohorts. Booking Holdings and Airbnb are relevant competitive read-throughs, not automatic beneficiaries or losers.

Near term, price action may reward guidance beats; over 1–3 months, handset sell-through, segment margins, and booking/conversion trends matter more. Over 6–18 months, the semiconductor question is whether non-phone revenue becomes profitable and repeatable; for travel, whether demand holds as pricing normalizes. Contrarian risk: investors may over-credit management forecasts before segment economics are independently visible. Without valuation and consensus detail, avoid chasing the initial moves.

Key Decisions for Investors

• Prefer QCOM to ARM on relative weakness, not as an unhedged momentum buy: Qualcomm has nearer-term diversification evidence, while Arm’s incremental case leans more heavily on a distant CPU target. Keep the pair small until comparable segment economics and valuation are checked; unwind if Qualcomm’s non-phone growth stalls or Arm demonstrates material CPU revenue ahead of schedule.
• Treat EXPE as a tactical long only on a post-reaction pullback, contingent on subsequent bookings and adjusted EBITDA margin updates confirming that volume growth is not being bought through discounting. Reassess if management cuts either outlook measure or US conversion weakens.
• Watch QCOM handset revenue and automotive/data-center segment profitability over the next 1–3 months; deterioration in both would falsify the diversification thesis. For ARM, track disclosed CPU customer deployments and realized revenue against the fiscal 2027–28 ambition rather than relying on confidence statements.
• No broad semiconductor or travel-sector trade is warranted from this report alone: missing valuation, consensus positioning, and independently verifiable segment-margin data could materially change the risk/reward.